Belgium: Ambitious Reform Of The Medical Devices Regulatory Framework

Last Updated: 10 January 2013
Article by Florence Verhoestraete and Christel Brion

The medical devices sector covers a wide range of products, from simple bandages to highly sophisticated devices such as pacemakers, as well as contact lenses, prostheses, medical equipment for hospital use, etc. This sector is extremely innovative, especially in Europe, and generates around EUR 95 billion annually (Eucomed figures for the EU, Norway and Switzerland).

Unlike medicinal products, medical devices do not usually require a marketing authorisation but, on the other hand, must generally bear the CE mark in order to be freely circulated in the EU.

The regulatory framework for medical devices, while undoubtedly valuable, has come under fire on a number of occasions, recently following the worldwide scandal surrounding PIP breast implants. Indeed, it was revealed that these French implants are more prone to rupture and leakage than others due to the fact that they contain unapproved industrial silicone rather than medical-grade fillers.

To avoid such problems in the future, the competent authorities and medical devices sector are currently working together to revise and reinforce the regulatory framework applicable to medical devices.

In this regard, the European Commission recently adopted and submitted to the European Parliament and the Council two proposals for regulations on medical devices. A key measure in the reform is the introduction of a Unique Device Identification (UDI) system, which will enhance the post-market safety of medical devices, help to reduce medical errors, and contribute to the fight against counterfeiting.

In Belgium, the Minister of Social Affairs and Public Health, Laurette Onkelinx, did not wish to await completion of the European reform and has already prepared a plan to enhance monitoring of the sector and ensure better traceability of medical devices. In implementing the plan, priority will be given to implantable medical devices, which are considered to pose greater risks.

This ambitious reform should be completed by 2016. Indeed, working groups are currently thrashing out measures to implement the main pillars of the plan, namely improved identification and traceability of medical devices and enhanced monitoring and materiovigilance (i.e. the monitoring of possible incidents associated with the use of medical devices). These measures will have to be passed by royal decree, in line with the future European measures.

Improved identification and traceability

The plan provides for the mandatory registration of any implantable medical device upon entry into distribution in Belgium. The manufacturer or distributor must submit information about the quality, security and efficacy of the device to the Federal Agency for Medicines and Health Products as well as to the pricing and reimbursement authorities.

This registration requirement will be phased in progressively, in April 2014 for the most common implants (e.g. hip prostheses and pacemakers) and April 2016 for all other implantable devices.

In addition, every implant placement must be registered by the relevant healthcare professional by April 2014. Healthcare professionals must also provide the patient with a so-called implant card containing useful information about the device (eg. date of expiry). This card serves as the patient's guarantee that the implant has been distributed through lawful channels.

This system will allow the authorities, in the event of problems, to know at any given time where a device is located and to alert the healthcare professionals and patients concerned.

Enhanced monitoring and safety

In October 2013, a new framework for the supply of medical devices will be introduced, involving (public and hospital) pharmacies.

In order to allow better monitoring of the sector by the authorities, the plan provides, amongst other things, for the reinforcement of inspections at manufacturers, distributors, hospitals and private clinics. The authorities will recruit 41 additional inspectors for this purpose. These heightened measures are already being felt in the sector of implantable devices, which has witnessed a sharp increase in the number of inspections since September.


Finally, the plan provides for the introduction of materiovigilance contact points and a mandatory standard procedure to notify incidents to the authorities. These obligations will be applicable to any party that supplies or makes available a medical device. Hospitals and distributors will be allowed to comply with these measures on a voluntary basis as from January 2013. They will however become mandatory for everyone in the sector in October 2013.

"The Belgian reform of the medical devices sector, which originates from the PIP scandal, has given rise to real 'screening' of the entire regulatory framework applicable to medical devices and will guarantee patients safer and better monitored devices", explains Richard Van den Broeck, director of UNAMEC, the Belgian trade association for the medical devices sector. "It is a very ambitious reform, whose implementation will be complex given the diversity in the sector. UNAMEC is in favour of reasonable implementation of the plan, so that the various players in the sector can continue to function 'normally', without unreasonable administrative burdens, while continuing to foster innovation and preserving competitiveness."

Finally, as the sector has agreed to finance the plan, it should be cost-neutral for the Belgian federal budget. 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Practice Guides
by Mondaq Advice Centres
Relevancy Powered by MondaqAI
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions